Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
43 participants
INTERVENTIONAL
2013-04-30
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
With the emergence of the internet, health care professionals are changing the way they approach diabetes management. Internet Blood Glucose Monitoring Systems (IBGMS) are aimed at keeping blood glucose levels normal or in the range of acceptable levels to prevent the complications associated with diabetes. The Principal Investigators have completed a randomized clinical trial supporting the efficacy of IBGMS (1,2).
Patient satisfaction of reporting platform is essential to encourage patient reporting and participation in IBGMS. In this study, we wish to compare two different types of meters which will be used to internet blood glucose monitoring: the BG Star Meter (Conventional Meter), and the iBG Star Group (iPhone Technology).
Purpose and Rationale
Patients who are more satisfied with their meter and internet reporting platform are more likely to participate in an internet monitoring system. Patients often lack the motivation to report to their endocrinologist. With increased reporting to their healthcare professional, patients are more likely to benefit from such a system. This study aims to compare two types of meters and their respective internet reporting platforms to encourage patient participation.
Objectives
Our main goal is to compare the two types of meters.
Primary Outcomes Include:
1. Patient Satisfaction as measured by the "Diabetes Treatment Satisfaction Questionnaire" (DTSQ)
2. Frequency of reporting to endocrinologist
3. Number of Self-Monitoring Blood Glucose (SMBG) tests
4. Time taken to teach each patient the platforms
Research Design/Methods
Sample Size: 50 patients will be randomized into two groups:
BG Star Group (Conventional Meter) 25 patients will use the (conventional) BG star meter in which patients will upload their readings onto a computer and send in their readings via email.
IBG Star Group (iPhone Technology) 25 patients will be randomized to the iBGstar system will upload their readings to their iPhone and send in their readings using the iPhone.
Patients will be recruited from a Physician's private office.
Both the (Conventional meter) BG star and iBG star (iPhone Technology) group will be asked to perform SMBG 3 or more times per day and to upload their metered glucose values online every 2 weeks to be reviewed by the doctor.
Inclusion criteria:
* Type 1s
* Type 2s, can be on insulin, oral antihyperglycemic agents, or in combination.
* Willingness to test blood glucose levels a minimum of 3 times daily
* Willingness to be randomized
* Trained in self-blood glucose monitoring
* Internet Access
Exclusion criteria: Patients who do not meet the above criteria or are not willing to participate will not be included in the study.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Management of diabetes is an evolving challenge to health care professionals. The fluctuations of glucose levels over the lifetime of patients with diabetes can lead to complications such as nephropathy, neuropathy, retinopathy and cardiovascular diseases. Although diabetes is a chronic disease, it can be controlled with use of medications (oral agents or insulin), and/or changes in life-style and diet.
With the emergence of the internet, health care professionals are changing the way they approach diabetes management. Internet Blood Glucose Monitoring Systems (IBGMS) are aimed at keeping blood glucose levels normal or in the range of acceptable levels to prevent the complications associated with diabetes. The Principal Investigators have completed a randomized clinical trial supporting the efficacy of IBGMS (1,2).
Patient satisfaction of reporting platform is essential to patient reporting and participation in IBGMS. In this study, we wish to compare two different types of meters which will be used to internet blood glucose monitoring: the BG Star Meter (Conventional Meter), and the iBG Star Group (iPhone Technology).
Purpose and Rationale
Patients who are more satisfied with their meter and internet reporting platform are more likely to participate in an internet monitoring system. Patients often lack the motivation to report to their endocrinologist. With increased reporting to their healthcare professional, patients are more likely to benefit from such a system. This study aims to compare two types of meters and their respective internet reporting platforms to encourage patient participation.
Objectives
Our main goal is to compare the two types of meters.
Primary Outcomes Include:
1. Patient Satisfaction as measured by the "Diabetes Treatment Satisfaction Questionnaire" (DTSQ)
2. Frequency of reporting to endocrinologist
3. Number of Self-Monitoring Blood Glucose (SMBG) tests
4. Time taken to teach each patient the platforms
Research Design/Methods
Sample Size: 50 patients will be randomized into two groups:
BG Star Group (Conventional Meter) 25 patients will use the (conventional) BG star meter in which patients will upload their readings onto a computer and send in their readings via email.
IBG Star Group (iPhone Technology) 25 patients will be randomized to the iBGstar system will upload their readings to their iPhone and send in their readings using the iPhone.
Patients will be recruited from a Physician's private office.
Both the (Conventional meter) BG star and iBG star (iPhone Technology) group will be asked to perform SMBG 3 or more times per day and to upload their metered glucose values online every 2 weeks to be reviewed by the doctor.
Inclusion criteria:
* Type 1s
* Type 2s, can be on insulin, oral antihyperglycemic agents, or in combination.
* Willingness to test blood glucose levels a minimum of 3 times daily
* Willingness to be randomized
* Trained in self-blood glucose monitoring
* Internet Access
Exclusion criteria: Patients who do not meet the above criteria or are not willing to participate will not be included in the study.
Confidentiality According to the guidelines of the University of British Columbia (UBC)/Providence Health Care Research Ethics Boards, the identity of participants will be kept confidential.
Data for each patient will be collected from the Clinical Research Coordinator and the Internet based glucose monitoring system. These data will only be accessed by the investigators and will be inputted into an Excel® spreadsheet where each patient will be given a unique identifier. All data pertaining to individual patients will be kept locked in the office of the study investigators.
Calculations and Statistics Statistical analysis will be performed on site by the researchers. Each group will complete the DTSQ. Questions revolve around satisfaction of treatment and are to be answered on a scale of 1 (very dissatisfied) to 6 (very Satisfied). Frequency of reporting will be determined through number of reports sent in per month. Total strip count will be recorded for each group. Time will be measured for the time it takes to train each patient in their respective meter/platform. All outcome measurements will be analysed using independent samples t-tests. Participants will only be identified by coded initials and a number to protect privacy.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
BG Star (Conventional Meter)
25 patients will use the (conventional) BG star meter in which patients will upload their readings onto a computer and send in their readings via email.
BG Star Meter (Conventional) Internet Blood Glucose Reporting
Patients in BG Star Meter Group will report using BG software through uploading information onto a computer and sending readings to their endocrinologist via email
IBG Star Group (iPhone)
25 patients will be randomized to the iBGstar system will upload their readings to their iPhone and send in their readings using the iPhone.
iBG Star (iphone) Internet Blood Glucose Method
25 patients will be randomized to the iBGstar system will upload their readings to their iPhone and send in their readings using the iPhone.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
BG Star Meter (Conventional) Internet Blood Glucose Reporting
Patients in BG Star Meter Group will report using BG software through uploading information onto a computer and sending readings to their endocrinologist via email
iBG Star (iphone) Internet Blood Glucose Method
25 patients will be randomized to the iBGstar system will upload their readings to their iPhone and send in their readings using the iPhone.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Type 2s, can be on insulin, oral antihyperglycemic agents, or in combination.
* Willingness to test blood glucose levels a minimum of 3 times daily
* Willingness to be randomized
* Trained in self-blood glucose monitoring
* Internet Access
Exclusion Criteria
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Endocrine Research Society
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Hugh Tildesley
Clinical Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Endocrine Research Society
Vancouver, British Columbia, Canada
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Tildesley HD, Mazanderani AB, Ross SA. Effect of Internet therapeutic intervention on A1C levels in patients with type 2 diabetes treated with insulin. Diabetes Care. 2010 Aug;33(8):1738-40. doi: 10.2337/dc09-2256.
Related Links
Access external resources that provide additional context or updates about the study.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IBG star study
Identifier Type: -
Identifier Source: org_study_id